Sequoia Financial Advisors LLC Buys Shares of 5,807 Cabot Corporation $CBT

Key Points

• Sequoia Financial Advisors LLC acquired 5,807 shares of Cabot Corporation valued at approximately $436,000, signaling growing interest in the specialty chemicals sector.
• Institutional investors own a significant portion (93.18%) of Cabot's stock, with several firms recently increasing their stakes during the first quarter of the year.
• Wall Street analysts have mixed ratings on Cabot, with a consensus of "Hold" and a target price of $85.00, reflecting cautious optimism about the company's future performance.

Sequoia Financial Advisors LLC bought a new stake in Cabot Corporation (NYSE:CBT - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 5,807 shares of the specialty chemicals company's stock, valued at approximately $436,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. American Century Companies Inc. lifted its holdings in shares of Cabot by 13.2% during the 1st quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company's stock worth $124,566,000 after acquiring an additional 174,921 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Cabot by 8.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,426,693 shares of the specialty chemicals company's stock worth $118,606,000 after acquiring an additional 108,397 shares during the period. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Cabot by 1.7% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,190,886 shares of the specialty chemicals company's stock worth $99,010,000 after acquiring an additional 19,333 shares during the period. Copeland Capital Management LLC lifted its holdings in shares of Cabot by 5.8% during the 1st quarter. Copeland Capital Management LLC now owns 805,504 shares of the specialty chemicals company's stock worth $66,970,000 after acquiring an additional 44,132 shares during the period. Finally, LSV Asset Management lifted its holdings in shares of Cabot by 318.0% during the 1st quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company's stock worth $47,476,000 after acquiring an additional 434,434 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CBT shares. Weiss Ratings reiterated a "hold (c)" rating on shares of Cabot in a report on Wednesday, October 8th. UBS Group set a $82.00 target price on shares of Cabot and gave the stock a "neutral" rating in a research report on Tuesday, August 5th. Finally, Mizuho dropped their target price on shares of Cabot from $90.00 to $88.00 and set an "outperform" rating for the company in a research report on Friday, October 3rd. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $85.00.

Cabot Stock Up 1.4%

Shares of NYSE:CBT opened at $70.64 on Tuesday. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. Cabot Corporation has a 52-week low of $66.50 and a 52-week high of $117.46. The company has a 50 day moving average of $77.19 and a two-hundred day moving average of $76.60. The company has a market capitalization of $3.76 billion, a price-to-earnings ratio of 9.23 and a beta of 0.88.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.80 by $0.10. Cabot had a net margin of 11.14% and a return on equity of 25.68%. The company had revenue of $923.00 million during the quarter, compared to the consensus estimate of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. As a group, analysts forecast that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Insider Transactions at Cabot

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total value of $9,072,486.08. Following the completion of the sale, the chief executive officer owned 361,518 shares of the company's stock, valued at $28,661,147.04. This trade represents a 24.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 3.03% of the stock is owned by company insiders.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.